Skip to main content
IP

Ipsen Pharma Singapore PTE. LTD.

Ipsen is a global biopharmaceutical company developing specialty care medicines in oncology, rare disease and neuroscience, with operations in 88 countries.

Ipsen Pharma Singapore PTE. LTD. is the Singapore entity of Ipsen, a global mid-sized biopharmaceutical company founded in 1929 by Dr. Henri Beaufour. The group's work concentrates on specialty care medicines, with technical domains spanning biopharmaceutical research and development, drug discovery and new molecular entity development. Therapeutic focus areas are oncology, rare disease and neuroscience, with an emphasis on conditions of high unmet medical need.

The company states an R&D ambition of delivering at least one new molecular entity or meaningful new indication every year. Ipsen employs more than 5,000 professionals worldwide and operates in 88 countries, reaching patients across five continents, with global hubs in the United States, France and the United Kingdom. The organisation describes its culture as entrepreneurial, combining the resources of a large company with the agility of a smaller one.

Nearly a century after its founding, Ipsen continues to be research- and innovation-driven, with a stated mission of improving patients' lives. Further information is available at https://ipsen.com/.

1 Open job

We use cookies

We use cookies to understand how this board is used and to improve it. Analytics run only if you accept. Cookie Policy